Cilengitide in Treating Patients With Unresectable or Metastatic Melanoma

Clinical trial NCT00082875 · TERMINATED

Trial details

NCT number: NCT00082875
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Stage III Melanoma Stage IV Melanoma

Start date: 2004-03-01
Primary completion: 2006-07-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.